Tag: skin lesions

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsSkin lesions

Polymatech Electronics Limited Announces Completion of PCB Manufacturing Facility in Europe

Commercial Credit, Inc. Closes $75 Million Senior Unsecured Notes Offering

PLANT-BASED EGG BRAND SECURES FIRST U.S. STORES

Tag: skin lesions

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us